Hiroshi Kiyono
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications
RESEARCH AND DEVELOPMENT STRATEGY FOR THE NEXT GENERATION OF MUCOSAL VACCINES
Journal: Arerugi = [Allergy]
Published: August 10, 2026
Sublingual bivalent vaccination with PspA-C-CPE and Alcaligenes lipid A induces protective immunity against both Streptococcus pneumoniae and Clostridium perfringens.
Journal: Research square
Published: July 10, 2026
Apurinic/apyrimidinic endonuclease 1 prevents oxidative DNA damage in intestinal epithelial cells induced by genotoxic Escherichia coli NC101.
Journal: Redox biology
Published: April 26, 2026
Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG Antibodies.
Journal: Molecular pharmaceutics
Published: March 26, 2026
Zymosan-adjuvanted intranasal norovirus virus-like particle vaccine induces antiviral mucosal immune responses in infant mice.
Journal: Mucosal immunology
Published: December 08, 2025
Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancer.
Journal: Science translational medicine
Published: November 12, 2025
Gut mucin fucosylation dictates the entry of botulinum toxin complexes.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025
Alcaligenes lipid A as a sublingual adjuvant to augment protective immune responses in the respiratory and gastrointestinal tracts.
Journal: International immunology
Published: March 04, 2025
Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice.
Journal: Circulation research
Published: March 03, 2025
An adjuvant database for preclinical evaluation of vaccines and immunotherapeutics.
Journal: Cell chemical biology
Published: February 07, 2025
Gut mucin fucosylation dictates the entry of botulinum toxin complexes.
Journal: Nature communications
Published: November 09, 2024
Organoid phenotypic screening identified glycyrrhizin that confers protection against tumor necrosis factor-induced cell death.
Journal: Stem cell reports
Published: August 16, 2024
Last Updated: 09/26/2026